Media coverage
1
Media coverage
Title First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome Media name/outlet India Pharma News Country/Territory India Date 6/05/20 Persons Alan Moskowitz, Emilia Bagiella, Annetine Gelijns